{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:37:29Z","timestamp":1789529849893,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer, Inc"},{"DOI":"10.13039\/100007313","name":"MD Anderson Cancer Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institutional Core","award":["CA16672"],"award-info":[{"award-number":["CA16672"]}]},{"name":"Institutional Core","award":["AI109025"],"award-info":[{"award-number":["AI109025"]}]},{"name":"National Institutes of Health and Astellas Pharma","award":["R01 CA180279"],"award-info":[{"award-number":["R01 CA180279"]}]},{"DOI":"10.13039\/100006988","name":"John S. Dunn Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,15]]},"DOI":"10.1093\/cid\/cix297","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T12:04:14Z","timestamp":1490702654000},"page":"216-225","source":"Crossref","is-referenced-by-count":60,"title":["Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999\u20132015"],"prefix":"10.1093","volume":"65","author":[{"given":"Sang Taek","family":"Heo","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston;"},{"name":"Department of Infectious Diseases, Jeju National University School of Medicine, Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Tatara","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston;"},{"name":"Department of Bioengineering, Rice University, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Jim\u00e9nez-Ortigosa","sequence":"additional","affiliation":[{"name":"Public Health Research Institute\u2013Rutgers Biomedical and Health Sciences, Newark, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell E.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Tarrand","sequence":"additional","affiliation":[{"name":"Department of Microbiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tverdek","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel D.","family":"Albert","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[{"name":"Center of Expertise in Mycology, Radboudumc\/Canisius Wilhelmina Hospital, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[{"name":"Center of Expertise in Mycology, Radboudumc\/Canisius Wilhelmina Hospital, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios G.","family":"Mikos","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Rice University, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Perlin","sequence":"additional","affiliation":[{"name":"Public Health Research Institute\u2013Rutgers Biomedical and Health Sciences, Newark, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"key\n\t\t\t\t20180328172324_CIT0001","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1054\/drup.2001.0185","article-title":"Membrane and cell wall targets in Aspergillus fumigatus","volume":"4","author":"Beauvais","year":"2001","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20180328172324_CIT0002","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328172324_CIT0003","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3201\/eid2201.151308","article-title":"Azole resistance of Aspergillus fumigatus in immunocompromised patients with invasive aspergillosis","volume":"22","author":"van der Linden","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328172324_CIT0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drup.2009.09.002","article-title":"Azole-resistance in Aspergillus: proposed nomenclature and breakpoints","volume":"12","author":"Verweij","year":"2009","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20180328172324_CIT0005","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.00502-15","article-title":"High-level pan-azole-resistant aspergillosis","volume":"53","author":"van Ingen","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328172324_CIT0006","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180328172324_CIT0007","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/fmb.14.27","article-title":"Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms","volume":"9","author":"Chowdhary","year":"2014","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20180328172324_CIT0008","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Espinel-Ingroff","year":"2010","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328172324_CIT0009","doi-asserted-by":"crossref","first-page":"i13","DOI":"10.1093\/jac\/dkm427","article-title":"Issues in antifungal susceptibility testing","volume":"61","author":"Johnson","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328172324_CIT0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20180328172324_CIT0011","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) consensus group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328172324_CIT0012","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","article-title":"Antifungal drug resistance of pathogenic fungi","volume":"359","author":"Kontoyiannis","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328172324_CIT0013","first-page":"19","article-title":"Azole containing agar plates as a screening tool for azole resistance of Aspergillus fumigatus","volume":"52","author":"Van der Linden","year":"2009","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20180328172324_CIT0014","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/IAI.65.4.1335-1344.1997","article-title":"Characterization of the Aspergillus nidulans aspnd1 gene demonstrates that the ASPND1 antigen, which it encodes, and several Aspergillus fumigatus immunodominant antigens belong to the same family","volume":"65","author":"Calera","year":"1997","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328172324_CIT0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.steroids.2007.11.005","article-title":"Ergosterol biosynthesis pathway in Aspergillus fumigatus","volume":"73","author":"Alcazar-Fuoli","year":"2008","journal-title":"Steroids"},{"key":"key\n\t\t\t\t20180328172324_CIT0016","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling","volume":"54","author":"Snelders","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172324_CIT0017","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/AAC.05990-11","article-title":"Azole preexposure affects the Aspergillus fumigatus population in patients","volume":"56","author":"Alanio","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172324_CIT0018","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328172324_CIT0019","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1128\/AAC.05003-14","article-title":"Azole drug import into the pathogenic fungus Aspergillus fumigatus","volume":"59","author":"Esquivel","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172324_CIT0020","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1128\/AAC.47.11.3592-3597.2003","article-title":"Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172324_CIT0021","first-page":"e00536","article-title":"Genomic context of azole resistance mutations in Aspergillus fumigatus determined using whole-genome sequencing","volume":"6","author":"Abdolrasouli","year":"2015","journal-title":"MBio"},{"key":"key\n\t\t\t\t20180328172324_CIT0022","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.23441","article-title":"Changes in causes of death over time after treatment for invasive aspergillosis","volume":"112","author":"Wingard","year":"2008","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180328172324_CIT0023","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"key\n\t\t\t\t20180328172324_CIT0024","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/S1473-3099(16)30138-4","article-title":"In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management","volume":"16","author":"Verweij","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328172324_CIT0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01491-16","article-title":"Pharmacodynamics of voriconazole against wild-type and azole-resistant Aspergillus flavus isolates in a nonneutropenic murine model of disseminated aspergillosis","volume":"61","author":"Rudramurthy","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172324_CIT0026","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/AAC.00256-16","article-title":"Are the TR46\/Y121F\/T289A mutations in azole-resistant aspergillosis patient acquired or environmental?","volume":"60","author":"Buil","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172324_CIT0027","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1164\/rccm.201510-2104LE","article-title":"Voriconazole-susceptible and voriconazole-resistant Aspergillus fumigatus coinfection","volume":"193","author":"Kolwijck","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180328172324_CIT0028","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","author":"Chong","year":"2016","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/2\/216\/24266367\/cix297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T14:20:34Z","timestamp":1601821234000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/65\/2\/216\/3097898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,3,31]]},"published-print":{"date-parts":[[2017,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix297","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,15]]},"published":{"date-parts":[[2017,3,31]]}}}